Article summarizes ISMP alerts on potential safety issues with products being introduced in the United States to help ease shortages due to the COVID-19 pandemic, including neuromuscular blockers and propofol.
For the full text, visit Pharmacy Times online.
More News
Awardees Focused on Safety Technology, Second Victims
New Survey Reveals Shortages are Negatively Affecting Patient Care, Causing Harm
This article appeared on the LA Times website on September 5, 2023.